Arcus Biosciences, Inc. Share Price
NYSE: RCUS | Mid CapArcus Biosciences, Inc. Stock Performance
Arcus Biosciences, Inc. Share Price Today
As of 9 October 2026, Arcus Biosciences, Inc.'s share price is $23.82. The stock opened at $24.27, compared to its previous close of $24.52. During today's trading session, Arcus Biosciences, Inc.'s share price traded between $22.82 and $24.27, with an average price of $23.55. Over the past 52 weeks, the stock has recorded a high of $31.68 and a low of $14.28. In terms of performance, Arcus Biosciences, Inc.'s share price has declined by 6.66% over the last six months and is up 20.79% on a year-on-year basis.
Arcus Biosciences, Inc. Share Price Chart
Arcus Biosciences, Inc. Quarterly Profit & Loss
All figures in USD
Arcus Biosciences, Inc. Annual Profit & Loss
All figures in USD
About Arcus Biosciences, Inc.
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.
Arcus Biosciences, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $25.75 | $23.77 | -8.22% |
Sep 2026 | $29.41 | $25.90 | -15.36% |
Aug 2026 | $27.70 | $30.60 | +8.32% |
Jul 2026 | $30.91 | $28.25 | -8.32% |
Jun 2026 | $25.21 | $30.82 | +21.39% |
May 2026 | $25.41 | $25.39 | -0.53% |
Apr 2026 | $21.95 | $25.52 | +18.04% |
Mar 2026 | $20.39 | $21.62 | +6.03% |
Feb 2026 | $21.07 | $20.39 | -3.07% |
Jan 2026 | $23.55 | $21.04 | -11.73% |
Dec 2025 | $25.68 | $23.83 | -8.71% |
Nov 2025 | $20.01 | $26.11 | +32.38% |